Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons

Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Departme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2002-07, Vol.51 (7), p.2056-2065
Hauptverfasser: DUNN-MEYNELL, Ambrose A, ROUTH, Vanessa H, LING KANG, GASPERS, Larry, LEVIN, Barry E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2065
container_issue 7
container_start_page 2056
container_title Diabetes (New York, N.Y.)
container_volume 51
creator DUNN-MEYNELL, Ambrose A
ROUTH, Vanessa H
LING KANG
GASPERS, Larry
LEVIN, Barry E
description Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey Abstract Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase (GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing. Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical role for GK as a regulator of glucosensing in both GE and GI neurons in the brain. Footnotes Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu . Received for publication 14 March 2002 and accepted in revised form 18 April 2002. ARC, arcuate nucleus; [Ca 2+ ] i , intracellular C
doi_str_mv 10.2337/diabetes.51.7.2056
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmed_primary_12086933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A89269264</galeid><sourcerecordid>A89269264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</originalsourceid><addsrcrecordid>eNpt0l9v0zAQAHALgVhX-AI8oAiJCYml-E8cJ4-jGqVSYS8g8WY5ziXxltrFTsT27XHXjqqoOluWTj_7bOsQekPwjDImPtVGVTBAmHEyEzOKef4MTUjJypRR8es5mmBMaEpEKc7QeQi3GOM8xkt0Rigu8pKxCdos-lG7O2NVgGQZkqGDZGXuoH9IvkEsMDifuCZ5VAFsMLZNjE0-u6F7SqbX99oMUCfK1v9yS9uZ6jE7Bzt41SffYfTOhlfoRaP6AK_36xT9_HL9Y_41Xd0slvOrVarzTAwpV2VGeU6KRjd1RRnHtKo1xVCWmtKSEt4wmgGtK16wmpeFjlFhVelGgM4Im6KL3bkb736PEAa5NkFD3ysLbgxSkCIXVOAI3_0Hb93obbybpCTeRVCSRXS5Q63qQRrbuPgm3YKF-DRnoTExfVWUNI9jy9MTPEYNa6NP-Q9HPpIB7odWjSHIYrE6openqHZ9Dy3I-IfzmyNOd1x7F4KHRm68WSv_IAmW2y6ST10kOZFCbrsobnq7_5KxWkN92LJvmwje74EKWvWNV1abcHBMCMbjnKKPO9eZtvtjPByqnSj7FwE53yU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216477214</pqid></control><display><type>article</type><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</creator><creatorcontrib>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</creatorcontrib><description>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey Abstract Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase (GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing. Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical role for GK as a regulator of glucosensing in both GE and GI neurons in the brain. Footnotes Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu . Received for publication 14 March 2002 and accepted in revised form 18 April 2002. ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited; GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial hypothalamic nucleus. DIABETES</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.51.7.2056</identifier><identifier>PMID: 12086933</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Animals ; Biochemistry and metabolism ; Biological and medical sciences ; Biological transport ; Brain - drug effects ; Brain - enzymology ; Brain - physiology ; Brain research ; Carotid Artery, Internal ; Central nervous system ; Diabetes ; Diabetes research ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic - drug effects ; Genes, fos - drug effects ; Glucokinase - genetics ; Glucokinase - metabolism ; Glucose ; Glucose - administration &amp; dosage ; Glucose - pharmacology ; Glucose metabolism ; In Situ Hybridization ; Infusions, Intra-Arterial ; Insulin ; Neurons ; Neurons - drug effects ; Neurons - enzymology ; Neurons - physiology ; Neuropeptides ; Obesity ; Obesity - metabolism ; Physiological aspects ; Physiological transport ; Physiology ; Rats ; Rats, Sprague-Dawley ; Transcription, Genetic - drug effects ; Vertebrates: nervous system and sense organs ; Weight Gain</subject><ispartof>Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2056-2065</ispartof><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 American Diabetes Association</rights><rights>COPYRIGHT 2002 American Diabetes Association</rights><rights>Copyright American Diabetes Association Jul 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</citedby><cites>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13773577$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12086933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUNN-MEYNELL, Ambrose A</creatorcontrib><creatorcontrib>ROUTH, Vanessa H</creatorcontrib><creatorcontrib>LING KANG</creatorcontrib><creatorcontrib>GASPERS, Larry</creatorcontrib><creatorcontrib>LEVIN, Barry E</creatorcontrib><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey Abstract Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase (GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing. Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical role for GK as a regulator of glucosensing in both GE and GI neurons in the brain. Footnotes Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu . Received for publication 14 March 2002 and accepted in revised form 18 April 2002. ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited; GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial hypothalamic nucleus. DIABETES</description><subject>Animals</subject><subject>Biochemistry and metabolism</subject><subject>Biological and medical sciences</subject><subject>Biological transport</subject><subject>Brain - drug effects</subject><subject>Brain - enzymology</subject><subject>Brain - physiology</subject><subject>Brain research</subject><subject>Carotid Artery, Internal</subject><subject>Central nervous system</subject><subject>Diabetes</subject><subject>Diabetes research</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Genes, fos - drug effects</subject><subject>Glucokinase - genetics</subject><subject>Glucokinase - metabolism</subject><subject>Glucose</subject><subject>Glucose - administration &amp; dosage</subject><subject>Glucose - pharmacology</subject><subject>Glucose metabolism</subject><subject>In Situ Hybridization</subject><subject>Infusions, Intra-Arterial</subject><subject>Insulin</subject><subject>Neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Neurons - physiology</subject><subject>Neuropeptides</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Physiological aspects</subject><subject>Physiological transport</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Transcription, Genetic - drug effects</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>Weight Gain</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0l9v0zAQAHALgVhX-AI8oAiJCYml-E8cJ4-jGqVSYS8g8WY5ziXxltrFTsT27XHXjqqoOluWTj_7bOsQekPwjDImPtVGVTBAmHEyEzOKef4MTUjJypRR8es5mmBMaEpEKc7QeQi3GOM8xkt0Rigu8pKxCdos-lG7O2NVgGQZkqGDZGXuoH9IvkEsMDifuCZ5VAFsMLZNjE0-u6F7SqbX99oMUCfK1v9yS9uZ6jE7Bzt41SffYfTOhlfoRaP6AK_36xT9_HL9Y_41Xd0slvOrVarzTAwpV2VGeU6KRjd1RRnHtKo1xVCWmtKSEt4wmgGtK16wmpeFjlFhVelGgM4Im6KL3bkb736PEAa5NkFD3ysLbgxSkCIXVOAI3_0Hb93obbybpCTeRVCSRXS5Q63qQRrbuPgm3YKF-DRnoTExfVWUNI9jy9MTPEYNa6NP-Q9HPpIB7odWjSHIYrE6openqHZ9Dy3I-IfzmyNOd1x7F4KHRm68WSv_IAmW2y6ST10kOZFCbrsobnq7_5KxWkN92LJvmwje74EKWvWNV1abcHBMCMbjnKKPO9eZtvtjPByqnSj7FwE53yU</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>DUNN-MEYNELL, Ambrose A</creator><creator>ROUTH, Vanessa H</creator><creator>LING KANG</creator><creator>GASPERS, Larry</creator><creator>LEVIN, Barry E</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><author>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Biochemistry and metabolism</topic><topic>Biological and medical sciences</topic><topic>Biological transport</topic><topic>Brain - drug effects</topic><topic>Brain - enzymology</topic><topic>Brain - physiology</topic><topic>Brain research</topic><topic>Carotid Artery, Internal</topic><topic>Central nervous system</topic><topic>Diabetes</topic><topic>Diabetes research</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Genes, fos - drug effects</topic><topic>Glucokinase - genetics</topic><topic>Glucokinase - metabolism</topic><topic>Glucose</topic><topic>Glucose - administration &amp; dosage</topic><topic>Glucose - pharmacology</topic><topic>Glucose metabolism</topic><topic>In Situ Hybridization</topic><topic>Infusions, Intra-Arterial</topic><topic>Insulin</topic><topic>Neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Neurons - physiology</topic><topic>Neuropeptides</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Physiological aspects</topic><topic>Physiological transport</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Transcription, Genetic - drug effects</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUNN-MEYNELL, Ambrose A</creatorcontrib><creatorcontrib>ROUTH, Vanessa H</creatorcontrib><creatorcontrib>LING KANG</creatorcontrib><creatorcontrib>GASPERS, Larry</creatorcontrib><creatorcontrib>LEVIN, Barry E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUNN-MEYNELL, Ambrose A</au><au>ROUTH, Vanessa H</au><au>LING KANG</au><au>GASPERS, Larry</au><au>LEVIN, Barry E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>51</volume><issue>7</issue><spage>2056</spage><epage>2065</epage><pages>2056-2065</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey Abstract Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase (GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing. Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical role for GK as a regulator of glucosensing in both GE and GI neurons in the brain. Footnotes Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu . Received for publication 14 March 2002 and accepted in revised form 18 April 2002. ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited; GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial hypothalamic nucleus. DIABETES</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12086933</pmid><doi>10.2337/diabetes.51.7.2056</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2056-2065
issn 0012-1797
1939-327X
language eng
recordid cdi_pubmed_primary_12086933
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Biochemistry and metabolism
Biological and medical sciences
Biological transport
Brain - drug effects
Brain - enzymology
Brain - physiology
Brain research
Carotid Artery, Internal
Central nervous system
Diabetes
Diabetes research
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Enzymologic - drug effects
Genes, fos - drug effects
Glucokinase - genetics
Glucokinase - metabolism
Glucose
Glucose - administration & dosage
Glucose - pharmacology
Glucose metabolism
In Situ Hybridization
Infusions, Intra-Arterial
Insulin
Neurons
Neurons - drug effects
Neurons - enzymology
Neurons - physiology
Neuropeptides
Obesity
Obesity - metabolism
Physiological aspects
Physiological transport
Physiology
Rats
Rats, Sprague-Dawley
Transcription, Genetic - drug effects
Vertebrates: nervous system and sense organs
Weight Gain
title Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A34%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucokinase%20Is%20the%20Likely%20Mediator%20of%20Glucosensing%20in%20Both%20Glucose-Excited%20and%20Glucose-Inhibited%20Central%20Neurons&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=DUNN-MEYNELL,%20Ambrose%20A&rft.date=2002-07-01&rft.volume=51&rft.issue=7&rft.spage=2056&rft.epage=2065&rft.pages=2056-2065&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.51.7.2056&rft_dat=%3Cgale_pubme%3EA89269264%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216477214&rft_id=info:pmid/12086933&rft_galeid=A89269264&rfr_iscdi=true